200 Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity by upregulating HER2 in malignant pleural mesothelioma cells. (September 2015) - Okita, R.; Nojima, Y.; Maeda, A.; Yukawa, T.; Saisho, S.; Shimizu, K.; Nakata, M.